News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
160,775 Results
Type
Article (6414)
Company Profile (59)
Press Release (154302)
Multimedia
Podcasts (3)
Webinars (1)
Section
Business (53231)
Career Advice (180)
Deals (9333)
Drug Delivery (12)
Drug Development (20810)
Employer Resources (22)
FDA (3485)
Job Trends (3554)
News (84230)
Policy (6452)
Tag
Academia (521)
Accelerated approval (8)
Allergies (47)
Alliances (6895)
ALS (46)
Alzheimer's disease (475)
Antibody-drug conjugate (ADC) (89)
Approvals (3672)
Artificial intelligence (86)
Autoimmune disease (48)
Automation (8)
Bankruptcy (54)
Best Places to Work (3198)
Biosimilars (50)
Biotechnology (42)
Bladder cancer (61)
Brain cancer (15)
Breast cancer (213)
Cancer (1475)
Cardiovascular disease (120)
Career advice (157)
Career pathing (3)
CAR-T (53)
CDC (6)
Cell therapy (140)
Cervical cancer (15)
Clinical research (18294)
Collaboration (251)
Compensation (160)
Complete response letters (12)
COVID-19 (1041)
CRISPR (14)
C-suite (79)
Cystic fibrosis (45)
Data (2218)
Depression (25)
Diabetes (175)
Diagnostics (1675)
Digital health (6)
Diversity, equity & inclusion (3)
Drug discovery (49)
Drug pricing (30)
Drug shortages (3)
Duchenne muscular dystrophy (41)
Earnings (40836)
Editorial (7)
Employer branding (3)
Employer resources (22)
Events (26371)
Executive appointments (74)
FDA (4501)
Fibrodysplasia Ossificans Progressiva (3)
Frontotemporal dementia (11)
Funding (213)
Gene editing (23)
Generative AI (5)
Gene therapy (100)
GLP-1 (246)
Government (1116)
Grass and pollen (2)
Guidances (313)
Healthcare (5270)
HIV (17)
Huntington's disease (12)
IgA nephropathy (23)
Immunology and inflammation (67)
Immuno-oncology (15)
Indications (54)
Infectious disease (1114)
Inflammatory bowel disease (84)
Inflation Reduction Act (2)
Influenza (28)
Intellectual property (29)
Interviews (25)
IPO (6103)
IRA (4)
Job creations (540)
Job search strategy (135)
JPM (9)
Kidney cancer (6)
Labor market (30)
Layoffs (90)
Leadership (2)
Legal (1002)
Liver cancer (24)
Longevity (4)
Lung cancer (220)
Lymphoma (144)
Machine learning (5)
Management (7)
Manufacturing (113)
MASH (43)
Medical device (3714)
Medtech (3730)
Mergers & acquisitions (3479)
Metabolic disorders (375)
mRNA (36)
Multiple sclerosis (68)
NASH (1)
Neurodegenerative disease (78)
Neuropsychiatric disorders (17)
Neuroscience (790)
NextGen: Class of 2026 (1142)
Non-profit (1016)
Now hiring (8)
Obesity (153)
Opinion (20)
Ovarian cancer (39)
Pain (32)
Pancreatic cancer (54)
Parkinson's disease (58)
Partnered (6)
Patents (76)
Patient recruitment (96)
Peanut (25)
People (7998)
Pharmaceutical (9)
Pharmacy benefit managers (7)
Phase 1 (4742)
Phase 2 (7879)
Phase 3 (7475)
Pipeline (2728)
Policy (29)
Postmarket research (682)
Preclinical (1701)
Press Release (10)
Prostate cancer (72)
Psychedelics (6)
Radiopharmaceuticals (65)
Rare diseases (210)
Real estate (745)
Recruiting (12)
Regulatory (5438)
Reports (19)
Research institute (532)
Resumes & cover letters (28)
Rett syndrome (10)
RNA editing (2)
RSV (27)
Schizophrenia (49)
Series A (24)
Series B (22)
Service/supplier (2)
Sickle cell disease (23)
Special edition (10)
Spinal muscular atrophy (53)
Sponsored (6)
Startups (512)
Stomach cancer (2)
Supply chain (13)
Tariffs (36)
The Weekly (3)
Vaccines (314)
Venture capital (18)
Weight loss (98)
Women's health (19)
Worklife (3)
Date
Today (2)
Last 7 days (173)
Last 30 days (922)
Last 365 days (8197)
2026 (1716)
2025 (8221)
2024 (9220)
2023 (10572)
2022 (11861)
2021 (32761)
2020 (12062)
2019 (9429)
2018 (6995)
2017 (6722)
2016 (5373)
2015 (7184)
2014 (4889)
2013 (3426)
2012 (3755)
2011 (4212)
2010 (3658)
Location
Africa (105)
Alabama (12)
Alaska (1)
Arizona (38)
Arkansas (1)
Asia (9683)
Australia (1332)
California (3050)
Canada (964)
China (265)
Colorado (148)
Connecticut (167)
Delaware (121)
Europe (21959)
Florida (408)
Georgia (97)
Hawaii (1)
Idaho (8)
Illinois (229)
India (15)
Indiana (204)
Iowa (1)
Japan (146)
Kansas (74)
Kentucky (10)
Louisiana (12)
Maine (23)
Maryland (298)
Massachusetts (2224)
Michigan (66)
Minnesota (207)
Mississippi (1)
Missouri (27)
Montana (8)
Nebraska (1)
Nevada (28)
New Hampshire (22)
New Jersey (1107)
New Mexico (5)
New York (901)
North Carolina (369)
Northern California (1536)
Ohio (63)
Oregon (3)
Pennsylvania (654)
Puerto Rico (7)
Rhode Island (3)
South America (204)
South Carolina (4)
Southern California (1261)
Tennessee (38)
Texas (435)
United States (11161)
Utah (93)
Virginia (50)
Washington D.C. (9)
Washington State (263)
Wisconsin (25)
160,775 Results for "23".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Abbott acquisition of Exact Sciences set to close on March 23, 2026
March 20, 2026
·
5 min read
Press Releases
Cartesian Therapeutics to Participate in Upcoming Investor Conferences - February 23, 2026
February 23, 2026
·
1 min read
Press Releases
ICU Medical to Participate in Upcoming Investor Conferences - February 23, 2026
February 23, 2026
·
1 min read
Press Releases
23andMe Introduces Reconstructed Ancestors a First-of-Its-Kind DNA Discovery Tool
March 13, 2026
·
4 min read
Press Releases
Novo Nordisk A/S - share repurchase programme - February 23, 2026
February 23, 2026
·
2 min read
Approvals
J&J Wins FDA Nod for First Targeted Oral Anti-IL-23 Therapy for Plaque Psoriasis
Icotyde, co-developed by Johnson & Johnson and Protagonist Therapeutics, is backed by data from the Phase 3 ICONIC program, which, among other advantages, showed significant superiority over Bristol Myers Squibb’s Sotyktu.
March 18, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Spyre Therapeutics Announces Grants of Inducement Awards - January 23, 2026
January 26, 2026
·
1 min read
Press Releases
Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026
March 9, 2026
·
1 min read
Press Releases
Tarsus to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, February 23, 2026
February 18, 2026
·
1 min read
Press Releases
Alligator Bioscience Comments on Henlius Dosing First Patient in Phase 2/3 Breast Cancer Study of HLX22
March 2, 2026
·
2 min read
1 of 16,078
Next
